• Date Due: November 15, 2023
  • Author: Secretary of Health and Human Resources
  • Enabling Authority: Chapter 582 Enactment Clause 1. (Regular Session, 2023)
  • Description:
    Report on the findings and recommendations of the work group convened to analyze and review current reimbursement and operational challenges for medical practices that administer anti-cancer drugs in an in-office setting to patients whose costs for such treatment are paid for by Medicare, Medicaid, or TRICARE, and to consider the impact on and accessibility of such treatment for Medicaid, Medicare, and TRICARE patients.